Uncategorized

ROCKVILLE AND BALTIMORE, MARYLAND, February 18, 2014 – BioHealth Innovation, Inc. (BHI) and China Fortune Land Development Co., Ltd. (CFLD) announced today that they have signed an agreement to jointly manage a newly created Entrepreneur-In-Residence (EIR) position to be located at the BHI headquarters in Rockville, Maryland. This first-of-its-kind position will lead in the scouting of technologies and partnership opportunities in life science hubs in the U.S. and China. 

“We’re very pleased to advance our partnership with BHI,” said Mr. Hu Zhen Yu, Vice President for CFLD, a company specializing in investment and operation of industrial areas in China, including science parks. “Our organizations first had a chance to connect in person when BHI’s CEO Rich Bendis traveled with a delegation from Montgomery County, Maryland, to China. Now, we look forward to filling this new EIR position, which will help to identify talented businesses and commercial prospects for our collaborative efforts.”

The new EIR will evaluate life science technologies in both China and the U.S. markets; provide a strategic plan for start-up companies; advise on opportunities for new ventures; and lead the commercial strategy for mature assets. This would be BHI’s 5th EIR since the program’s inception two years ago.

Originally published in the Baltimore Business Journal

By Brian Darmody

Where’s the nation’s second largest concentration of academic, federal and private sector research spending? California? Massachusetts? According to the National Science Foundation, it’s Maryland, equating to billions of dollars in research investment in the Maryland economy. First place New Mexico has a relatively small rural population and presence of two major federal nuclear research labs.

But Maryland has something New Mexico doesn’t — proximity to Washington, D.C.

Washington is home to the nation’s government, but also the National Academies, technology trade associations, international corporations, embassies, media, regulatory agencies, foundations, and science agencies.

DATE March 13, 2014 • TIME 8:00am – 4:30pm • LOCATION Nelson Mullins 101 Constitution Ave NW, Ste. 900 Washington, DC

The HealthTechNet Investor Day matches entrepreneurs and investors in a series of 30-minute meetings. There are no speakers and no panels, just individual meetings between entrepreneurs and investors. To register, fill out the the form below by Friday, February 14.

Companies and investors must register below. If you have questions, please email Jessica Straus at unconference@ec.co. 

 Startup Package for Client Companies

BHI works with a supporting network of renowned professional service providers that share the same vision for growing Maryland’s biohealth sector. These professionals work in partnership with BHI to support client companies achieve their goals. They understand the nature and needs of startup companies, and offer preferred rates for client companies. We are proud to work these esteemed organizations in serving the Central Maryland biohealth ecosystem.

If you would like to become a part of BHI’s network of startup package providers to work with unique companies and projects as evaluated and accelerated through our Venture Commercialization model, please send information no longer than 2 pages stating your qualifications against a category of support and include your preferred pricing in offering these services.

February 3 and 4, 2014, 8:00pm ET/5:00pm PT

About the Workshop: Now on its ninth run, the NIH SBIR Phase I Program for First-Time Applicants is a very practical step-by-step, four-hour online “How-To” workshop over two evenings to help researchers, faculty members, graduate students, post-docs and entrepreneurs create a SBIR company and apply to the NIH SBIR program in April of 2014. This workshop includes a post-course review of the applicant’s proposed SBIR application by our experts before submission to the NIH. As an added benefit, your SBIR companies will be included on NCET2’s newsletters that is sent out to VCs, angel investors, Global 1000 companies, and government funders.

About the SBIR Program: The NIH SBIR/STTR program is one of the federal government’s best mechanisms to continue funding innovative life science research after traditional research funding has been exhausted. The objective of the program is to dramatically increase the impact of innovations derived from original federally funded R&D, and as such is an ideal program to fund university commercialization of research through new university/faculty/student startup companies. Phase I can be for up to $150,000 for 6 months. Phase II can be for up to $1 million for 2 years. After Phase I and II, the company should have eliminated enough technical and scientific risk of the original research that the company is ready for outside investor funding or product sales in the company sustainability final Phase III of the SBIR program.